Many transplant patients are given the drug cyclosporine to suppress their immune systems and prevent rejection. But cyclosporine also increases the risk of cancer, always thought to be a side effect of the depressed Immune system. A new study shows that cyclosporine directly affects tumour growth and may be the culprit.
|Original language||English (US)|
|Number of pages||2|
|State||Published - Feb 11 1999|
ASJC Scopus subject areas